Synthetics Stance In NDI Guidance Raises Red Flag For Industry
This article was originally published in The Tan Sheet
FDA's draft guidance on new dietary ingredient notifications already is arousing fierce pushback from the supplement industry over what constitutes an NDI and which substances cannot be dietary ingredients at all.
You may also be interested in...
Herbalife Proposes FDA Use NDI Master Files To Reduce Notification Burden
Herbalife asks FDA to temper its position that every supplement product containing a new dietary ingredient require a full notification, instead proposing a streamlined process based around NDI master files.
CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology
FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.
FDA Errs On Estimates For NDIs, Claims Substantiation – CRN
FDA “grossly underestimated” firms’ costs for filing new dietary ingredient notifications and ignored their costs for substantiating claims, the Council for Responsible Nutrition says in July 25 comments.